Financing channel feed – Endpoints News

Financing channel feed

OrbiMed lines up $551M gamble on China, India biotech sectors

8 years ago

NEA-backed Nightstar Therapeutics sets sights on an $86M IPO to fund PhIII gene therapy study

8 years ago

Star team quietly raises $21M to launch the latest immuno-oncology startup Torque

8 years ago

Celgene, Google double down on Armo’s PhIII immuno-oncology drug with $67M round

8 years ago

Viking leads a $46M raise for a struggling aTyr Pharma

8 years ago

Here’s why 23-year-old Laura Deming is betting $22M on anti-aging R&D

8 years ago

The best — and worst — biotech IPOs in the class of 2017

8 years ago

Atreca bags $35M B round for next-gen immuno-oncology drug pipeline

8 years ago

With a big stake in hand, Samantha Du files for $115M IPO for Zai Lab

8 years ago

Apellis grabs $60M to pay for a looming PhIII showdown with Alexion's Soliris

8 years ago

Zealand bags a $77M IPO haul as investors embrace another biotech offering

8 years ago

Eyeing an IPO, Sutro retools its $1B I/O deal with Celgene but stays focused on BCMA

8 years ago

Orbimed partner in search of a cure for Parkinson’s launches new gene therapy player

8 years ago

SoftBank bets $1.1B on Roivant CEO Vivek Ramaswamy’s brash new biotech strategy

8 years ago

China biotech bags a $57M round as it races to complete R&D, manufacturing site

8 years ago

Updated: Acorda shares surge as a big investor pushes it to the auction block

8 years ago

Clementia keeps the biotech IPO party going with $120M play on an upsized offering

8 years ago

Amplyx grabs $67M to fund a pivotal drive to the FDA with an anti-fungal aimed at a lethal threat

8 years ago

Milestone Pharma preps a leap into PhIII cardio study with $55M round backed by Novo

8 years ago

A fast-moving entry in the gene editing race is speeding to the clinic, fueled by an $83.5M round

8 years ago

Sienna Bio bags $65M in the latest successful biotech IPO

8 years ago

British billionaire Jim Mellon and high-profile partners roll the dice on an anti-aging upstart

8 years ago

Canaan reels in a jumbo $800M fund with a big focus on a new wave of biotech startups

8 years ago

Riders on the storm: VenatoRx bags a $42M round to back antibiotics pipeline

8 years ago

First page Previous page 137 138 139140141 142 143 Next page Last page